Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca, Bristol diabetes drug disappoints in key test
AstraZeneca, Bristol diabetes drug disappoints in key test
AstraZeneca, Bristol diabetes drug disappoints in key test
Submitted by
admin
on June 19, 2013 - 10:28am
Source:
Reuters
News Tags:
Bristol-Myers Squibb
AstraZeneca
diabetes
Onglyza
Headline:
AstraZeneca, Bristol diabetes drug disappoints in key test
Do Not Allow Advertisers to Use My Personal information
